The latest Deutsche Stiftung Weltbevölkerung (DSW) paper on Filling the Global Health Gaps - How could EU R&I and funding contribute?, supported by EVI, highlights the need for Preventive tools, Vaccines, Treatments, Diagnostics to tackle poverty-related and neglected disease (PRNDs).
“While investments in, and lessons learned from PRND R&I contributed to a faster, more coordinated response to COVID-19, highlighting its key contribution to pandemic preparedness and response, there is an urgent need to build on the COVID-19 experience to catalyse research and product development for PRNDs.”
Vaccines are the most powerful public health tool in the fight against communicable diseases. However no licensed vaccines are available for the majority of PRNDs. Four main gaps and areas to addressed through Horizon Europe funding are identified:
Highest burden NTDs have no licensed vaccine
The urgent need for new TB vaccines
HIV vaccines need further support
Second-generation malaria vaccines are needed
EVI, in close collaboration with its partners from across the world, continues to pursue and support efforts for the development of much needed safe, effective and low-cost vaccines against PRNDs, such as malaria, diarrhoeal disease (e.g. Shigella) as well as strategies to address antimicrobial resistance (AMR).
Read the full report to know more on how Horizon EU health cluster can contribute.
Image: DSW International